Table 1 Description of the patients (n = 753).
Patient characteristics | Value | Tumor characteristics | Value |
---|---|---|---|
Age, years | 70 (63–76) | Kinki criteria | |
Gender | Â B1 | 279 | |
 Male | 553 |  B2 | 381 |
 Female | 200 |  B3 | 93 |
Etiology | TNM-LCSGJ | ||
 HCV | 516 |  II | 205 |
 HBV | 71 |  III | 548 |
 HCV + HBV | 15 | Size of the largest nodules, cm | 3 (1.9–4) |
 nonBnonC | 151 |  < 1 | 2 |
ECOG, PS 0/1 | 753/0 |  1–2 | 190 |
Total bilirubin, mg/dL | 0.9 (0.6–1.3) |  2–3 | 168 |
AST, U/L | 54 (37–75) |  3–4 | 179 |
ALT, U/L | 41 (26.75–63) |  4–6 | 135 |
Albumin, g/dL | 3.5 (3.1–3.9) |  6–10 | 63 |
Platelets, × 104/μL | 10.1 (7.1–13.9) |  ≥ 10 | 16 |
Prothrombin time, % | 85 (73.5–97.9) | Number of nodules | 5 (3–7) |
ALBI score | -2.22 (-2.59—-1.79) |  2 | 127 |
mALBI grade | Â 3 | 81 | |
 1 | 184 |  4 | 167 |
 2a | 150 |  5 | 95 |
 2b | 355 |  6–7 | 100 |
 3 | 64 |  8–9 | 35 |
Child–Pugh score |  ≥ 10 or diffuse | 148 | |
 5 | 300 | Naïve/recurrence | 279/474 |
 6 | 242 | AFP, ng/dL | 39.6 (10.2–262.5) |
 7 | 118 | DCP, mAU/mL | 111 (29–728.75) |
 ≥ 8 | 93 |  |  |